Survey: Biopharma gets a bad grade on gender diversity

John Carroll

The industry doesn't do a very good job when it comes down to the way it handles . And if you're a woman in this business, chances are you have a distinctly bleaker view of things than your male colleagues. That's the bottom line from last week's informal from FierceBiotech.

FierceBiotech News

Share This Post

Related Articles

Leave a Reply

© 2019 Global Regulatory Science. All rights reserved. Site Admin · Entries RSS · Comments RSS